Constructing prognostic model incorporating the 2004 WHO/ISUP classification for patients with non-muscle-invasive urothelial tumours of the urinary bladder

Journal of Clinical Pathology

Volumn 63, Issue 10, 2010, Pages 910-915

  Pan, Chin Chen ^a   Chang, Yen Hwa ^b   Chen, Kuang Kuo ^b   Yu, Hui Jung ^a   Sun, Chih Hao ^a   Ho, Donald M T ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; DOXORUBICIN; EPIRUBICIN; MITOMYCIN C; THIOTEPA;

ADULT; AGE; AGED; ARTICLE; BOOTSTRAPPING; CANCER GRADING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NOMOGRAM; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROPORTIONAL HAZARDS MODEL; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; TRANSURETHRAL RESECTION; TUMOR CLASSIFICATION; UROGENITAL TRACT TUMOR;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, PAPILLARY; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NOMOGRAMS; RECURRENCE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 77957836360     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.079764     Document Type: Article

References (24)

1. Eble JN, Sauter G, Epstein JI, et al. World Health Organization classification of tumours. pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC Press, 2004.
2. Babjuk M, Oosterlinck W, Sylvester R, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 2008;54:303-14.
3. Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006;24:3967-72.
4. Karakiewicz PI, Shariat SF, Palapattu GS, et al. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 2006;176:1354-61.
5. Margulis V, Lotan Y, Montorsi F, et al. Predicting survival after radical cystectomy for bladder cancer. BJU Int 2008;102:15-22. (Pubitemid 351799452)
6. Shariat SF, Karakiewicz PI, Palapattu GS, et al. Nomograms provide improved accuracy for predicting survival after radical cystectomy. Clin Cancer Res 2006;12:6663-76.
7. Shariat SF, Karakiewicz PI, Ashfaq R, et al. Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy. Cancer 2008;112:315-25.
8. Hong SJ, Cho KS, Han M, et al. Nomograms for prediction of disease recurrence in patients with primary Ta, T1 transitional cell carcinoma of the bladder. J Korean Med Sci 2008;23:428-33.
9. Shariat SF, Zippe C, Ludecke G, et al. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder. J Urol 2005;173:1518-25. (Pubitemid 40524761)
10. Sylvester RJ, van der Meijden AP, Oosterlinck W, et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466-5. (Pubitemid 43259554)
11. Akritas MG. Bootstrapping the Kaplan-Meier estimator. J Am Stat Assoc 1986;81:1032-8.
12. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-87.
13. Allard P, Bernard P, Fradet Y, et al. The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index. Br J Urol 1998;81:692-8. (Pubitemid 28316632)
14. Flamm J, Havelec L. Factors affecting survival in primary superficial bladder cancer. Eur Urol 1990;17:113-18. (Pubitemid 20082436)
15. Kiemeney LA, Witjes JA, Heijbroek RP, et al. Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer. J Urol 1993;150:60-4.
16. Leblanc B, Duclos AJ, Benard F, et al. Long-term followup of initial ta grade 1 transitional cell carcinoma of the bladder. J Urol 1999;162:1946-50.
17. Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, et al. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000;163:73-8.
18. Mulders PF, Meyden AP, Doesburg WH, et al. Prognostic factors in pTa-pT1 superficial bladder tumours treated with intravesical instillations. The Dutch South-Eastern Urological Collaborative Group. Br J Urol 1994;73:403-8.
19. Parmar MK, Freedman LS, Hargreave TB, et al. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). J Urol 1989;142:284-8.
20. Alsheikh A, Mohamedali Z, Jones E, et al. Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology. Mod Pathol 2001;14:267-72. (Pubitemid 32298910)
21. Oosterhuis JW, Schapers RF, Janssen-Heijnen ML, et al. Histological grading of papillary urothelial carcinoma of the bladder: prognostic value of the 1998 WHO/ISUP classification system and comparison with conventional grading systems. J Clin Pathol 2002;55:900-5.
22. Pich A, Chiusa L, Formiconi A, et al. Biologic differences between noninvasive papillary urothelial neoplasms of low malignant potential and low-grade (grade 1) papillary carcinomas of the bladder. Am J Surg Pathol 2001;25:1528-33. (Pubitemid 33096968)
23. Schned AR, Andrew AS, Marsit CJ, et al. Survival following the diagnosis of noninvasive bladder cancer: WHO/International Society of Urological Pathology versus WHO classification systems. J Urol 2007;178:1196-200.
24. Pan CC, Chang YH, Chen KK, et al. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol 2010;133:788-95.